Trial Profile
The ACER-study - the effects of galantamine on the variability and stability of walking among patients with Alzheimer's disease. De ACER-studie - effecten van galantamine op de variabiliteit en stabiliteit van het looppatroon bij patienten met de ziekte van Alzheimer.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 18 Nov 2012
Price :
$35
*
At a glance
- Drugs Galantamine (Primary)
- Indications Alzheimer's disease
- Focus Pharmacodynamics
- Acronyms ACER
- 27 Feb 2012 New trial record